Gillinder Bedi
Associate Professor; Head of Substance Use Research at Orygen and Principal Research Fellow at the Centre for Youth Mental Health, University of Melbourne
Data updated
Research Footprint
Gillinder Bedi appears in 7 tracked papers (2010–2025), most studied alongside MDMA, Placebo and Psilocybin, across Interpersonal Functioning & Social Connectedness, PTSD and Substance Use Disorders (SUD).
Most-cited paper: Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others (245 citations).
Frequent co-authors: Harriet de Wit, Suresh Muthukumaraswamy and Matthew Baggot.
Background & Research
Gillinder Bedi is a clinical psychologist and academic researcher based at Orygen and the University of Melbourne. Her earlier training and postdoctoral work focused on the acute effects of MDMA/ecstasy in humans, including cognition, mood, and social behavior, and she has also held a faculty position at Columbia University Medical Center/New York State Psychiatric Institute. Her current research centers on substance use, experimental medicine, and the methodology, safety, and ethics of psychedelic-assisted psychotherapy research.
Key Impact
Gillinder Bedi is a leading human psychopharmacology and psychedelic/MDMA researcher whose work has helped define the acute social and behavioral effects of MDMA and inform the safety and ethics of psychedelic-assisted therapy.
Collaboration Network
6 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Gillinder Bedi is associated with.
The University of Melbourne
The University of Melbourne is a leading public research university in Australia, with medical and psychological sciences programmes contributing to psychedelic and mental health research.
View stakeholder →University of Chicago
The University of Chicago (UChicago) is a private research university located in the Hyde Park neighborhood of Chicago, Illinois. It is known for rigorous scholarship and influential research across the humanities, social sciences, and sciences.
View stakeholder →Monash University
academicThe Clinical Psychedelic Lab, led by Dr. Paul Liknaitzky, conducts robust clinical trials exploring the efficacy and safety of psychedelic-assisted therapies for various mental health conditions within the Australian healthcare context.
View stakeholder →